Hemorrhage control in the battlefield: Role of new hemostatic agents
Hemorrhage control in the battlefield: Role of new hemostatic agents
复制标题
DOI：
10.7205/milmed.170.1.63
复制
发表时间：
2005-01-01
影响因子：
1.2
通讯作者：
Rhee, P
中科院分区：
文献类型：
--
作者：
Alam, HB;Burris, D;Rhee, P
不受控制的出血是可预防的战斗相关死亡的主要原因。绝大多数死亡发生在伤者被送往治疗机构之前的现场。早期控制出血仍然是治疗战斗伤亡的最有效策略。最近，许多止血剂被部署到前线，可用于在手术控制血源之前止血。本文的目的是总结有关这些止血剂的背景信息、其使用的适应症和基本原理，以及可能影响有效性的这些产品的特性。
Uncontrolled hemorrhage is the leading cause of preventable combat-related deaths. The vast majority of these deaths occur in the field before the injured can be transported to a treatment facility. Early control of hemorrhage remains the most effective strategy for treating combat casualties. A number of hemostatic agents have recently been deployed to the warfront that can be used to arrest bleeding before surgical control of the source. The purpose of this article is to summarize the background information regarding these hemostatic agents, indications and rationale for their use, and characteristics of these products that may impact effectiveness.